Your browser doesn't support javascript.
loading
p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis.
Jiang, Chao; Xu, Rui; Li, Xiao-Xing; Wang, Yan-Yan; Liang, Wen-Qian; Zeng, Ju-Deng; Zhang, Shan-Shan; Xu, Xiao-Yi; Yang, Yang; Zhang, Mei-Yin; Wang, Hui-Yun; Zheng, X F Steven.
Afiliação
  • Jiang C; a State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong , China.
  • Xu R; b Department of Internal Medicine , Cancer Center of Guangzhou Medical University , Guangzhou , Guangdong , China.
  • Li XX; a State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong , China.
  • Wang YY; a State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong , China.
  • Liang WQ; a State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong , China.
  • Zeng JD; a State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong , China.
  • Zhang SS; a State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong , China.
  • Xu XY; a State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong , China.
  • Yang Y; a State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong , China.
  • Zhang MY; a State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong , China.
  • Wang HY; a State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine , Sun Yat-Sen University Cancer Center , Guangzhou , Guangdong , China.
  • Zheng XFS; c Rutgers Cancer Institute of New Jersey and Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers , The State University of New Jersey , New Brunswick , NJ , USA.
Cell Cycle ; 16(18): 1673-1682, 2017 Sep 17.
Article em En | MEDLINE | ID: mdl-28841361

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribonucleotídeo Redutases / Transdução de Sinais / Neoplasias do Colo do Útero / Progressão da Doença / Proteínas de Ciclo Celular / Proteínas Proto-Oncogênicas c-akt / Transição Epitelial-Mesenquimal Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Cell Cycle Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribonucleotídeo Redutases / Transdução de Sinais / Neoplasias do Colo do Útero / Progressão da Doença / Proteínas de Ciclo Celular / Proteínas Proto-Oncogênicas c-akt / Transição Epitelial-Mesenquimal Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Cell Cycle Ano de publicação: 2017 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos